BioLoomics

Drug discovery is notoriously slow and expensive. With thousands of potential targets and a traditionally linear approach to testing, scale has always been a bottleneck. BioLoomics developed a breakthrough: a proprietary single-cell screening method that enables high-throughput discovery of target-degrading antibodies. To bring this deep-tech innovation to market, they partnered with us for a full brand and digital build, designed to clearly articulate their value to both investors and pharma partners.

Navigating scientific complexity

BioLoomics operates at the intersection of synthetic biology, AI, and spatial-temporal data. Their platform screens millions of individual cells to surface rare but highly valuable interactions, unlocking novel therapeutic pathways. To tell this story with both clarity and credibility, we developed messaging that translated scientific nuance into real-world value: tailored for investors, researchers, and collaborators alike.

Translating insight into identity

We drew inspiration from the company’s core insight: that drug development hinges on identifying outlier cells. The visual identity reflects this with motifs of focus, detection, and emergence: communicated through logo design, custom illustrations, and a restrained yet modern color system. Typography and image treatments reinforce the sense of scientific precision and clarity.

Designing the digital experience

Built on Webflow, the BioLoomics website was designed to grow with the business. The site leverages a split light and dark layout for navigability, subtle animations for storytelling, and performance-tuned infrastructure (Cloudflare CDN, AWS hosting) for seamless delivery. The result is a platform that speaks equally well to technical and non-technical audiences, and reflects the ambition of a category-defining company.

From launch to lift-off

The new brand and website launched alongside BioLoomics’ $8.7M seed round announcement, helping position the company as a serious contender in next-gen biologics. The platform now serves as a foundation for business development, hiring, and fundraising.